1. Home
  2. KTCC vs BYSI Comparison

KTCC vs BYSI Comparison

Compare KTCC & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

N/A

Current Price

$3.83

Market Cap

44.7M

Sector

Technology

ML Signal

N/A

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$0.72

Market Cap

35.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KTCC
BYSI
Founded
1969
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7M
35.8M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
KTCC
BYSI
Price
$3.83
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.2K
2.0M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,871,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$0.67
52 Week High
$4.42
$2.44

Technical Indicators

Market Signals
Indicator
KTCC
BYSI
Relative Strength Index (RSI) 46.76 31.28
Support Level $3.82 N/A
Resistance Level $4.10 $1.30
Average True Range (ATR) 0.23 0.12
MACD -0.03 -0.00
Stochastic Oscillator 18.94 7.38

Price Performance

Historical Comparison
KTCC
BYSI

About KTCC Key Tronic Corporation

Key Tronic Corporation provides electronic manufacturing services, including engineering, materials management, manufacturing and assembly, in-house testing, and distribution to various countries. The company serves diverse industries such as pest control, personal protection, air purification, automotive, medical technology, and utilities inspection equipment. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly. Key Tronic operates manufacturing facilities in the United States, Vietnam, and Mexico, recently expanding with a new facility in Arkansas. Revenue is generated mainly through contract manufacturing and service agreement.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: